Pfizer Inc

Type: Company
Name: Pfizer Inc (Pfizer Inc New York)
Nationality: United States
Web Address: http://www.pfizer.com/
Fact Sheet: Fact Sheet for Pfizer Inc
First reported 8 hours ago - Updated 5 hours ago - 2 reports

Pfizer Has Potential To Grow Despite Decreasing Sales

Home » Blogs » Pfizer (PFE) is the world's largest research-based pharmaceutical company. It discovers, manufactures and leads the global market in prescription drugs and healthcare products. The company is struggling with deteriorating sales due to the ... [Published BioPortfolio - 5 hours ago]
First reported 15 hours ago - Updated 14 hours ago - 2 reports

Pfizer PT Raised to $29.00 (PFE)

MKM Partners increased their price target on shares of Pfizer (NYSE: PFE)A number of other analysts have also recently weighed in on PFE. Analysts at Independent Research GmbH reiterated a ?hold? rating on shares of Pfizer in a research note to investors ... [Published American Banking News - 14 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 3 reports

Pfizer: split-off

Shareholders can exchange $100 worth of the drugmaker’s stock for $108 of Zoetis stock and they can select which shares they wish to hold ... [Published FT.com - Lex - 16 hours ago]
First reported May 23 2013 - Updated 21 hours ago - 2 reports

Pfizer Inc. to Stay in Madison, 475 Jobs Saved

Two months after Pfizer announced the sale of its property at 5 Giralda Farms, the company says it's only moving across the corporate campus. Pfizer Consumer Health has entered into a lease agreement for its new headquarters at 1 Giralda Farms, and will ... [Published BioSpace - 21 hours ago]
First reported May 22 2013 - Updated 22 hours ago - 3 reports

Pfizer Inc. (PFE): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

Is Pfizer Inc. (NYSE: PFE ) a buy, sell, or hold? Hedge funds are buying. The number of long hedge fund positions inched up by 3 in recent months.To the average investor, there are a multitude of gauges market participants can use to analyze their holdings. ... [Published InsiderMonkey.com - 22 hours ago]
First reported May 23 2013 - Updated 23 hours ago - 9 reports

Scientist who invented HPV vaccine tackles MRSA

Kathrin Jansen of Pfizer is trying to stop MRSA, a super-resistant staph that kills more Americans each year than AIDS.CHICAGO — Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: She brought the cervical cancer vaccine ... [Published MSN News - 23 hours ago]
First reported May 22 2013 - Updated May 23 2013 - 13 reports

Pfizer To Spin-off Rest Of Zoetis

Share |Drug giant Pfizer Inc. (PFE) Wednesday said it will spin-off its majority stake in animal health business Zoetis Inc. (ZTS) through an exchange offer. Pfizer shareholders will be offered exchange of their Pfizer stock for Zoetis shares at a 7 percent ... [Published E-Forex - May 23 2013]
Entities: Zoetis Inc, Pfizer Inc, Rest
First reported May 23 2013 - Updated May 23 2013 - 2 reports

Ahead Of Schedule, Pfizer Prepares To Free Zoetis In Stock Swap

Home » Blogs » The Big Pharma intends to loosen its leash on its former animal health business come June when Pfizer shareholders will be given an option to swap their shares for Zoetis stock. Meanwhile, Pfizer continues its strategy to shift its focus ... [Published BioPortfolio - May 23 2013]
First reported May 22 2013 - Updated May 23 2013 - 6 reports

Pfizer to spin off Zoetis stake to shareholders

Pfizer said it will spin off its majority stake in animal health business Zoetis to shareholders by allowing them to swap Pfizer stock for Zoetis shares at a 7 per cent discount.Pfizer, the largest US drugmaker, sold Zoetis shares in an initial public ... [Published Irish Times - May 23 2013]
First reported May 22 2013 - Updated May 23 2013 - 15 reports

Pfizer to divest its animal health business

Pfizer has announced plans to wind down its interest in animal health group Zoetis in order to focus on its core biopharmaceuticals business.The US drug giant already sold a near 20% stake in the division in an initial public offering earlier this year ... [Published Pharma Times - May 23 2013]
First reported May 22 2013 - Updated May 22 2013 - 2 reports

Pfizer plans offering to pare Zoetis stake

TRENTON, N.J. - Drugmaker Pfizer Inc. plans to try to sell its controlling stake in its former animal health business, Zoetis Inc., through a voluntary stock exchange with Pfizer shareholders.Pfizer, the world's second-largest drugmaker, said Wednesday ... [Published Birmingham Star - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 2 reports

Pfizer plans offering to pare Zoetis stake

Both strategies are needed because Pfizer's revenue has dropped by several billion dollars a year as prescription drug sales have been hurt by worsening generic competition, particularly inexpensive copycat versions of its cholesterol blockbuster Lipitor, ... [Published Modesto Bee - May 22 2013]

Quotes

Responding to a questioner in the Irish parliament who said Apple's tax rate bordered on magic, Noonan replied: "Maybe there was a magician, but the magician wasn't living down in Cork. Because they are not tax resident in Ireland, they are not liable to Irish tax."
Doctors from the University of Turku in Finland wrote that "the overall benefit of statins still clearly outweighs the potential risk of incident diabetes"
"We have more than doubled our R&D productivity in the past four years" Stoeffels told the meeting, attributing the progress to a tighter focus on key therapeutic categories, selective sourcing of innovative technologies...
Contacted for comment on Thursday, Roche and Bayer did not reply, but Pfizer sent the following statement: "Pfizer is not aware of any information indicating the activities of any companies operating in the former GDR that were subsequently acquired by Pfizer failed to comply with the legal requirements or applicable internationals standards at that time." (Bayer—and perhaps others—also told the German media that all its global tests were conducted according to uniform standards.)

More Content

All (5856) | News (4168) | Reports (230) | Blogs (927) | Audio/Video (30) | Fact Sheets (40) | Press Releases (452)
sort by: Date | Relevance
MannKind Corporation (MNKD)’s Run to Glory [Published InsiderMonkey.com - 13 mins ago]
Two Found Dead, Cheerleader's Bullying Claims, ... [Published Long Valley Patch - 18 mins ago]
This Metric Says You Are Smart to Buy Sanofi SA... [Published InsiderMonkey.com - 53 mins ago]
AtheroNova Mentioned by Analyst in Life Science... [Published BayStreet.ca - 1 hour ago]
Irish finance minister says US Senate are misle... [Published Irish Central - 1 hour ago]
United Therapeutics: A Growth Stock With Good P... [Published Seeking Alpha - 2 hours ago]
Antares Pharma, Inc.: New Antares Pharma, Inc. ... [Published TransWorldNews - 2 hours ago]
Athersys, Inc.: New Athersys, Inc. company prof... [Published TransWorldNews - 3 hours ago]
JD Supra Corporate Brief: Gross Negligence, Rea... [Published JD Supra - 3 hours ago]
Statins may increase risk diabetes risk: study [Published Pharmaceutical Technology - 3 hours ago]
Royalty Pharma Discloses Acceptance Levels of O... [Published Street Insider - 3 hours ago]
Auxilium Pharmaceuticals, Inc. To Present At Th... [Published Barchart - 3 hours ago]
J&J expects to file 10 new pharma products by 2017 [Published PMLive - 4 hours ago]
Germans Find New Evidence of Shady Soviet-Era D... [Published BusinessWeek - 4 hours ago]
Phacilitate Partnering for Vaccine Emerging Mar... [Published Pharmalicensing - 4 hours ago]
Five Key Things About the SAC Insider Case [Published Bloomberg - 5 hours ago]
Low levels of pneumonia resistance predicted fo... [Published Farmers Guardian - 5 hours ago]
Pfizer Has Potential To Grow Despite Decreasing... [Published BioPortfolio - 5 hours ago]
COGSTATE LIMITED: Company Secretary Appointment [Published 4 Traders - 6 hours ago]
Apple’s Tax Magic Leaves Irish Bondholders Unmo... [Published La Repubblica - 6 hours ago]
Amgen: Financial Analysis And Valuation [Published Seeking Alpha - 7 hours ago]
Pfizer Discontinues Late-Stage Trial of Inotuzu... [Published OncLive - 7 hours ago]
Offer Update [Published TrustNet - 7 hours ago]
Pfizer Has Potential To Grow Despite Decreasing... [Published Seeking Alpha - 8 hours ago]
Premier Global Alpha Growth fund continues to w... [Published TrustNet - 8 hours ago]
The Press Roundup [Published MoneyAM - 9 hours ago]
[Correspondence] Tofacitinib for rheumatoid art... [Published Lancet - 9 hours ago]
On Track with RFID? [Published Pharmaceutical & Medical Packaging News - 9 hours ago]
CARTONING AND LABELING: A Focus on Presentation [Published Pharmaceutical & Medical Packaging News - 9 hours ago]
EU Traceability Requirements for Advanced Ther... [Published FDA News - 11 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
NYT Columnist Joe Nocera laughably calls Tim Co... [Published The Unofficial Apple Weblog (TUAW) - 19 hours ago]
p style="text-align: center;"> As we reported previously, Tim Cook and two other Apple executives appeared before Congress earlier this week to discuss Apple's tax practices. The focus of the hearing centered on how Apple manages to keep the bulk ...
The Best Governance for Medicine ... is in Thai... [Published Health Care Renewal - 19 hours ago]
The Best Health Care System in the World?  Here in the US, a lot of people have been convinced that we have the best health care system in the world.  For example, during the 2012 US presidential campaign, Politi-Fact reported ,House Speaker John Boehner, ...
Pfizer (PFE) Showing Bullish Technicals But Cou... [Published MarketIntelligenceCenter.com - May 23 2013]
Pfizer Inc. (NYSE: PFE) closed Wednesday's trading session at $29.30. In the past year, the stock has hit a 52-week low of $21.40 and 52-week high of $31.15. Pfizer (PFE) stock has been showing support around $28.69 and resistance in the $30.35 range. ...
Another Look At Marketing Vs. R&D In Pharma [Published In the Pipeline - May 23 2013]
FiercePharma has some good figures to back up my posts the other day on R&D spending versus marketing . I mentioned how many people, when they argue that drug companies spend more on marketing than they do on research, are taking the entire SG&A ...
4 Healthcare Stock Stories For Midweek Investme... [Published Wall St. Cheat Sheet - May 23 2013]
GlaxoSmithKline ( NYSE:GSK ): Closing price $52.95GlaxoSmithKline and the Biomedical Advanced Research and Development Authority will work jointly in a first of its kind collaboration in support of the development of several antibiotics to fight antibiotic ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Pfizer to Split Off Rest of Zoetis Animal Healt... [Published FOX Business - Video - May 22 2013]
Viagra for Sale, and It's Not Spam [Published WSJ.com Video - Business - May 07 2013]
Viagra now being sold online, directly to custo... [Published CBS News Online - YouTube - May 07 2013]
Refill Frenzy: Pfizer, CVS to Sell Viagra Online [Published Bloomberg - YouTube - May 07 2013]
The Top Ten Stocks for April 30 [Published Bloomberg - YouTube - Apr 30 2013]
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Trace Earning Forecast for Bank of America, Pfi... [Published PR Newswire: Financial Services - May 23 2013]
Clinical Data on TetraLogic Pharmaceuticals’ Sm... [Published Business Wire - May 22 2013]
Zoetis To File Registration Statement; Comments... [Published Business Wire Professional Services News - May 22 2013]
Zoetis To File Registration Statement; Comments... [Published Business Wire Health News - May 22 2013]
Pfizer Announces Plan for Split-Off of Zoetis [Published Business Wire Professional Services News - May 22 2013]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.